|
CN105163730A
|
|
Methods and comp0stions for treatment of demyelinating diseases
|
|
US2014187643A1
|
|
Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing
|
|
AU2013201090A1
|
|
Methods for treating hiv-associated nuerological disease using polyamine analogs
|
|
EP2665471A2
|
|
Controlled release oral pharmaceutical dosage forms comprising mgbg
|
|
NZ597488A
|
|
Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
|
|
HUE033487T2
|
|
Mgbg for the regulation of osteopontin and the treatment of multiple sclerosis
|
|
US2007202515A1
|
|
Promac signature application
|
|
CN101300004A
|
|
Methods for treating viral infections using polyamine analogs
|
|
CA2598278A1
|
|
Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
|
|
EP1613263A2
|
|
Monitoring and treatment of amyotrophic lateral sclerosis
|
